NEJM Interview: Dr. Jerry Avorn on the 21st Century Cures Act’s potential implications for drug development and safety.

Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Avorn and A.S. Kesselheim. The 21st Century Cures Act - Will It Take Us Back in Time? N Engl J Med 2015;372:2473-5.